CARDINAL HEALTH INC (CAH) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:CAH - US14149Y1082 - Common Stock
200.62 USD
-0.49 (-0.24%)
ChartMill assigns a Buy % Consensus number of 82% to CAH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 218.73. This target is 9.03% above the current price.
CAH was analyzed by 22 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CAH.
In the previous month the buy percentage consensus was at a similar level.
CAH was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-09 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-11-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-04 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-03 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-31 | UBS | Maintains | Buy -> Buy |
| 2025-10-31 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-31 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-08-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-13 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-13 | Baird | Maintains | Outperform -> Outperform |
| 2025-08-12 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-07-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-06-13 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-06-13 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-06-12 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-06-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-06-03 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2025-05-05 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-02 | UBS | Maintains | Buy -> Buy |
| 2025-05-02 | Baird | Maintains | Outperform -> Outperform |
| 2025-04-29 | UBS | Maintains | Buy -> Buy |
| 2025-04-11 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-31 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-02-05 | Jefferies | Upgrade | Hold -> Buy |
| 2025-02-04 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-04 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-01-31 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-01-29 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-24 | JP Morgan | Maintains | Neutral -> Neutral |
CARDINAL HEALTH INC / CAH FAQ
Can you provide the average price target for CARDINAL HEALTH INC stock?
22 analysts have analysed CAH and the average price target is 218.73 USD. This implies a price increase of 9.03% is expected in the next year compared to the current price of 200.62.
What is the consensus rating for CAH stock?
The consensus rating for CARDINAL HEALTH INC (CAH) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.